Royce & Associates LP Iradimed Corp Transaction History

Royce & Associates LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$21.0 - $24.61 $18,480 - $21,656	-880 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$18.68 - $24.35 $1,494 - $1,948	80 Added 10.0%	880 $20,000
Q1 2020 May 12, 2020	SELL	$16.08 - $27.67 $2,106 - $3,624	-131 Reduced 14.07%	800 $17,000
Q4 2019 Feb 06, 2020	SELL	$21.11 - $25.92 $3,842 - $4,717	-182 Reduced 16.35%	931 $22,000
Q3 2019 Nov 13, 2019	BUY	$18.06 - $24.1 $8,145 - $10,869	451 Added 68.13%	1,113 $23,000
Q2 2019 Aug 12, 2019	BUY	$19.6 - $29.31 $901 - $1,348	46 Added 7.47%	662 $14,000
Q1 2019 May 09, 2019	BUY	$23.58 - $28.43 $4,197 - $5,060	178 Added 40.64%	616 $17,000
Q4 2018 Feb 11, 2019	SELL	$20.63 - $34.04 $453 - $748	-22 Reduced 4.78%	438 $11,000
Q3 2018 Nov 13, 2018	BUY	$20.6 - $37.15 $9,476 - $17,089	460 New	460 $17,000

140

6.59M

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $679M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.